USA successfully launched its second mission for Japanese customer, the Institute for Q-shu Pioneers of Space, iQPS. ‘The ...

Cathie Wood’s ARK line of ETFs added more 29,845 Tempus AI (TEM) stock after the company announced the acquisition of Deep 6 AI ...

Tempus AI has a twelve month low of $22.89 and a twelve month high of $91.45. The company has a debt-to-equity ratio of 8.17, a current ratio of 2.69 and a quick ratio of 2.55. Insider Activity ...

Cold Spring Harbor Laboratory's bid to lodge postdoctoral fellows on the grounds of a former school dormitory in Oyster Bay Cove won approval from the village's zoning board following a ...

The acquisition of Ambry Genetics, finalized in February 2025, further strengthens Tempus’ genomics capabilities by adding a West Coast lab and expanding inherited risk testing. Another ...

Skyrocketing 108% since the start of 2025, Tempus AI (NASDAQ: TEM), a company applying AI solutions to healthcare, has seen its stock perform exceptionally well this year. Investors have found the ...

Tempus AI's Q4 financials were slightly below expectations but aligned with preliminary results, presenting a buying opportunity due to raised 2025 revenue guidance. The company, a leader in ...

Forbes contributors publish independent expert analyses and insights. I write about the intersection of health care, technology and policy ...

Tempus AI held its IPO in June 2024 and is applying AI solutions to healthcare. Investors should watch several metrics to assess the company's growth prospects. While Tempus AI could reap big ...